Skip to main content

U.S. approves digital pill that tracks when patients take it



U.S. regulators on Tuesday approved the first digital pill with an embedded sensor to track if patients are taking their medication properly, marking a significant step forward in the convergence of healthcare and technology.

The medicine is a version of Otsuka Pharmaceutical Co Ltd’s established drug, Abilify, for schizophrenia, bipolar disorder and depression, containing a tracking device developed by Proteus Digital Health.

The system offers doctors an objective way to measure if patients are swallowing their pills on schedule, opening up a new avenue for monitoring medicine compliance that could be applied in other therapeutic areas.

Shares in Otsuka rose 2.5 per cent, after news of the U.S. Food and Drug Administration late on Monday.

The FDA said that being able to track ingestion of medicines prescribed for mental illness may be useful “for some patients”, although the ability of the digital pill to improve patient compliance had not been proved.

“The FDA supports the development and use of new technology in prescription drugs and is committed to working with companies to understand how technology might benefit patients and prescribers,” said Mitchell Mathis of the FDA’s Centre for Drug Evaluation and Research.

The system works by sending a message from the pill’s sensor to a wearable patch, which then transmits the information to a mobile application so that patients can track the ingestion of the medication on their smartphone.

About the size of a grain of salt, the sensor has no battery or antenna and is activated when it gets wet from stomach juices.

That completes a circuit between coatings of copper and magnesium on either side, generating a tiny electric charge.

In the longer term, such digital pills could also be used to manage patients with other complicated medicine routines, such as those suffering from diabetes or heart conditions.

Poor compliance with drug regimens is a common problem in many disease areas, especially when patients suffer from chronic conditions.

Proteus has been working on the pill tracking system for many years and the sensor used in Abilify MyCite was first cleared for use by the FDA in 2012.

The unlisted Californian company has attracted investments from several large healthcare companies, including Novartis AG, Medtronic Inc and St. Jude Medical Inc, as well as Otsuka.

Abilify MyCite is not approved to treat patients with dementia-related psychosis.

It also contains a boxed warning alerting health care professionals that elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. (Reuters/NAN)


Labels:

Comments

Post a Comment

Comment here

Popular posts from this blog

World’s first sex shop shuts down, declares bankruptcy

Germany’s pioneering sex shop chain, Beate Uhse, said Friday that it has filed for insolvency, as the empire started by a female World War II pilot fails to rise to the challenge posed by erotic e-commerce. In its hey day, the group sold lingerie, erotic films and sex products. Uhse began her foray into erotic business in 1946, when she put together a pamphlet called “Document X” describing how women could avoid pregnancy. In post-war Germany, her advice was in high demand and she sold thousands of copies of her brochures. The mail order business thrived and the former fighter pilot and member of the Luftwaffe opened in 1962 her first shop in the German town of Flensburg. Named Institute of Marital Hygiene, the store selling lingerie and contraceptives became the world’s first sex shop. Her activities often ran counter to the morality of post-war Germany and she was called before the courts in thousands of legal suits filed against her. Yet she remained frank and unashamed about...
Post a Comment
Read more

John McCain has brain cancer, his office says.

Veteran US Republican Senator John McCain has been diagnosed with brain cancer and is reviewing treatment options, according to his office. The options may include chemotherapy and radiation, his doctors said. The 80-year-old politician is in "good spirits" recovering at home. The tumour was discovered during a surgery to remove a blood clot from above his left eye last week. A Vietnam veteran, Mr McCain spent more than five years as a prisoner of war. The six-term senator and 2008 Republican presidential candidate underwent surgery at a clinic in Phoenix, in the state of Arizona, last Friday. Tissue analysis revealed that a primary brain tumour known as glioblastoma was associated with the clot, a statement from the Mayo Clinic said. "The senator's doctors say he is recovering from his surgery 'amazingly well' and his underlying health is excellent," it added.
Post a Comment
Read more

When will President Buhari be considered incapacitated?

AT the homestretch of the 2015 presidential election, the Goodluck Jonathan’s re-election campaign team challenged then candidate Muhammadu Buhari to a sport contest. When the gauntlet was left unpicked, the team in a follow up, set the internet abuzz with the juxtaposition of the pictures of President Jonathan and members of  his Federal Executive Council jogging and that of not-too-good- looking candidate Buhari. The challenge which came on the heels of simmering conjectures on the health condition of candidate Buhari was aimed at passing one message which is: President Jonathan is healthier than candidate Buhari to carry out the duties of the office of president of the Federal Republic of Nigeria. But was “health” given a premium in the election?  The vuvuzelas of the opposition party was so fortissimo that not even the yawping of Governor Ayo Fayose of Ekiti state could be heard. They rally-cried “Nigeria sai changi” and people responded wi...
Post a Comment
Read more